Platelets in Coronavirus Disease 2019.
作者信息
Larsen Julie Brogaard, Pasalic Leonardo, Hvas Anne-Mette
机构信息
Thrombosis and Haemostasis Research Unit, Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
Sydney Centres for Thrombosis and Haemostasis, Sydney, Australia.
出版信息
Semin Thromb Hemost. 2020 Oct;46(7):823-825. doi: 10.1055/s-0040-1710006. Epub 2020 Apr 30.
Abstract
摘要
相似文献
1
Platelets in Coronavirus Disease 2019.2019冠状病毒病中的血小板
Semin Thromb Hemost. 2020 Oct;46(7):823-825. doi: 10.1055/s-0040-1710006. Epub 2020 Apr 30.
2
Mechanisms involved in the development of thrombocytopenia in patients with COVID-19.与 COVID-19 患者血小板减少症发展相关的机制。
Thromb Res. 2020 Sep;193:110-115. doi: 10.1016/j.thromres.2020.06.008. Epub 2020 Jun 5.
3
Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病（COVID-19）中血小板异质性与宿主免疫反应的观点
Semin Thromb Hemost. 2020 Oct;46(7):826-830. doi: 10.1055/s-0040-1715093. Epub 2020 Sep 3.
4
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.血小板减少症与因新冠肺炎住院患者的不良预后独立相关。
Br J Haematol. 2020 Sep;190(5):e276-e279. doi: 10.1111/bjh.16950. Epub 2020 Aug 31.
5
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
6
Hemostatic laboratory derangements in COVID-19 with a focus on platelet count.新型冠状病毒肺炎患者止血实验室检查异常特征分析，重点关注血小板计数。
Platelets. 2020 Aug 17;31(6):740-745. doi: 10.1080/09537104.2020.1768523. Epub 2020 May 26.
7
Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.血小板减少作为新型冠状病毒肺炎的初始表现；病例系列及文献综述
Br J Haematol. 2020 Jun;189(6):1057-1058. doi: 10.1111/bjh.16769. Epub 2020 Jun 2.
8
Mechanism of thrombocytopenia in COVID-19 patients.新型冠状病毒肺炎患者血小板减少的机制。
Ann Hematol. 2020 Jun;99(6):1205-1208. doi: 10.1007/s00277-020-04019-0. Epub 2020 Apr 15.
9
COVID-19 coagulopathy vs disseminated intravascular coagulation.新型冠状病毒肺炎凝血病与弥散性血管内凝血
Blood Adv. 2020 Jun 23;4(12):2850. doi: 10.1182/bloodadvances.2020002197.
10
Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study.血小板参数与 2019 年冠状病毒病患者死亡率的相关性：回顾性队列研究。
Platelets. 2020 May 18;31(4):490-496. doi: 10.1080/09537104.2020.1754383. Epub 2020 Apr 16.
引用本文的文献
1
Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy.两例与腺病毒载体疫苗ChAdOx1-S（阿斯利康）相关的免疫性血小板减少症（ITP）及血小板生成素受体激动剂（TPO-RA）治疗后的良好反应
Hematol Rep. 2024 Sep 27;16(4):585-592. doi: 10.3390/hematolrep16040057.
2
Coagulopathy in COVID-19 and anticoagulation clinical trials.新型冠状病毒肺炎合并凝血病与抗凝临床试验
Best Pract Res Clin Haematol. 2022 Sep;35(3):101377. doi: 10.1016/j.beha.2022.101377. Epub 2022 Aug 23.
3
Short-term outcomes of COVID-19 in pregnant women unvaccinated for SARS-CoV-2 in the first, second, and third trimesters: a retrospective study.COVID-19 孕妇在第一、二、三孕期未接种 SARS-CoV-2 疫苗的短期结局：一项回顾性研究。
Sao Paulo Med J. 2022 Oct 28;141(4):e2022323. doi: 10.1590/1516-3180.2022.0323.R1.19082022. eCollection 2022.
4
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia.新冠病毒病（Covid-19）对常规实验室检测肝素诱导的血小板减少症能力的潜在影响。
Thromb J. 2022 Sep 26;20(1):55. doi: 10.1186/s12959-022-00411-0.
5
Polyphosphate in Antiviral Protection: A Polyanionic Inorganic Polymer in the Fight Against Coronavirus SARS-CoV-2 Infection.多聚磷酸盐在抗病毒保护中的作用：一种针对冠状病毒 SARS-CoV-2 感染的多阴离子无机聚合物。
Prog Mol Subcell Biol. 2022;61:145-189. doi: 10.1007/978-3-031-01237-2_7.
6
Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing.COVID-19疫情期间除病毒检测外的病理学应用：常规凝血和D-二聚体检测
Pathology. 2023 Feb;55(1):155-159. doi: 10.1016/j.pathol.2022.02.013. Epub 2022 May 28.
7
Ethnicity-Specific Features of COVID-19 Among Arabs, Africans, South Asians, East Asians, and Caucasians in the United Arab Emirates.阿联酋阿拉伯人、非洲人、南亚人、东亚人和高加索人 COVID-19 的种族特异性特征。
Front Cell Infect Microbiol. 2022 Mar 16;11:773141. doi: 10.3389/fcimb.2021.773141. eCollection 2021.
8
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.从进化角度看血管防御、止血、癌症和血小板生物学。
Cancer Metastasis Rev. 2022 Mar;41(1):147-172. doi: 10.1007/s10555-022-10019-5. Epub 2022 Jan 12.
9
Monocyte distribution width as a novel sepsis indicator in COVID-19 patients.单核细胞分布宽度作为 COVID-19 患者脓毒症的新指标。
BMC Infect Dis. 2022 Jan 4;22(1):27. doi: 10.1186/s12879-021-07016-4.
10
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia.COVID-19 肺炎住院患者的血栓预防和管理。
Lancet Respir Med. 2022 Feb;10(2):214-220. doi: 10.1016/S2213-2600(21)00455-0. Epub 2021 Nov 25.
本文引用的文献
1
Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China.107 例新型冠状病毒（SARS-CoV-2）感染患者从中国武汉两家医院出院的临床过程和转归。
Crit Care. 2020 Apr 30;24(1):188. doi: 10.1186/s13054-020-02895-6.
2
A Champion of Host Defense: A Generic Large-Scale Cause for Platelet Dysfunction and Depletion in Infection.宿主防御的捍卫者：感染导致血小板功能障碍和耗竭的一般性大规模原因。
Semin Thromb Hemost. 2020 Apr;46(3):302-319. doi: 10.1055/s-0040-1708827. Epub 2020 Apr 12.
3
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
4
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
5
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
6
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.严重 COVID-19 患者临床实验室数据测定的诊断效用。
J Med Virol. 2020 Jul;92(7):791-796. doi: 10.1002/jmv.25770. Epub 2020 Apr 10.
7
Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19.血小板与淋巴细胞比值与新型冠状病毒肺炎患者预后相关。
J Med Virol. 2020 Sep;92(9):1533-1541. doi: 10.1002/jmv.25767. Epub 2020 Mar 26.
8
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis.血小板减少症与严重的 2019 年冠状病毒病（COVID-19）感染相关：一项荟萃分析。
Clin Chim Acta. 2020 Jul;506:145-148. doi: 10.1016/j.cca.2020.03.022. Epub 2020 Mar 13.
9
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
10
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
Zotero 插件